solution for infusion.

DRUG2 trials

Sponsors

Odense University Hospital, European Foundation For The Study Of Chronic Liver Failure

Conditions

Liver cirrhosis

Phase 3

ALB-TRIAL: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

WithdrawnCTIS2022-501006-34-00

Odense University Hospital, European Foundation For The Study Of Chronic Liver FailureLiver cirrhosis

Target: 180Updated: 2022-10-05

ALB-TRIAL: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

RecruitingCTIS2022-501006-34-01

Odense University Hospital, European Foundation For The Study Of Chronic Liver FailureLiver cirrhosis

Start: 2023-03-29Target: 210Updated: 2025-10-07

Related Papers

Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial

BMJ Open2024-02-018 citations